Becton, Dickinson and Co. | BDX - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Abbott USD 928M 149M 2026-06
Agilent USD 339M 34M 2026-03
Align Technology USD 108.29M 4.48M 2026-06
AngioDynamics USD -6.35M 4.55M 2025-09
Baxter International USD 126M 141M 2026-06
Becton, Dickinson and Co. USD 377M 688M 2026-06
Bio-Rad Laboratories USD 371.4M 898.5M 2026-06
Boston Scientific USD 907M 434M 2026-06
Cooper Companies USD -77.9M 208.7M 2026-03
Danaher USD 870M 159M 2026-06
Dentsply International USD 37M 47M 2026-06
Dexcom USD 249.1M 49.6M 2026-06
Edwards Lifesciences USD 241.9M 138.8M 2026-06
Globus Medical USD 151.57M 27.27M 2026-06
Insulet USD 95M 3.9M 2026-06
Integra LifeSciences USD 4.48M 9.1M 2026-06
Intuitive Surgical USD 818.1M 3.4M 2026-06
J&J USD 5.53B 299M 2026-06
Medtronic USD 1.24B 100M 2026-03
Solventum Corp USD 92M 79M 2026-06
Stryker USD 1.28B 531M 2026-06
Tandem Diabetes Care USD -21.17M 775K 2026-06
Teleflex USD 99.69M 107.85M 2026-06
Terumo JPY 70.43B 44.06B 2026-06
Thermo Fisher Scientific USD 1.74B 85M 2026-06
Zimmer Biomet Holdings USD 198.3M 39.8M 2026-06